United States · FDA National Drug Code directory
chlorothiazide sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-305_84becbf0-39a2-48b9-9725-8945d191e410
- Product NDC
- 25021-305
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- chlorothiazide sodium
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151012
- Source listing expiry
- 20271231
Source-listed ingredients
- CHLOROTHIAZIDE SODIUM — 500 mg/18mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL · 25021-305-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →